Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Electrocardiogram, Fibrin D dimer, Full blood count, Hyperhidrosis
Clinical narrative: shortness of breath; allergic reaction; woke up with Swollen face/Mouth was not in the right place/Face looked as if she had a stroke/face swallow; chest pain; Pain all over her body; Sweating; Fever 100.3F; Can not go to work after the booster shot; Weak; Could not sleep; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), INSOMNIA (Could not sleep), CHEST PAIN (chest pain), PAIN (Pain all over her body) and HYPERHIDROSIS (Sweating) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient was totally healthy and had no heart issues or blood pressure issues. The patient did not use Botox for headaches or facial fillers.  Previously administered products included for Product used for unknown indication: AstraZeneca (2nd dose) and AstraZeneca (1st dose). Past adverse reactions to the above products included No adverse event with AstraZeneca and AstraZeneca.    On 26-Jul-2022 at 1:00 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jul-2022, the patient experienced INSOMNIA (Could not sleep), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can not go to work after the booster shot) and ASTHENIA (Weak). On 26-Jul-2022 at 10:00 PM, the patient experienced PYREXIA (Fever 100.3F). On 27-Jul-2022, the patient experienced CHEST PAIN (chest pain), PAIN (Pain all over her body) and HYPERHIDROSIS (Sweating). On 28-Jul-2022, the patient experienced SWELLING FACE (woke up with Swollen face/Mouth was not in the right place/Face looked as if she had a stroke/face swallow). On an unknown date, the patient experienced DYSPNOEA (shortness of breath) and HYPERSENSITIVITY (allergic reaction). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (shortness of breath), INSOMNIA (Could not sleep), CHEST PAIN (chest pain), PAIN (Pain all over her body), HYPERHIDROSIS (Sweating), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can not go to work after the booster shot), HYPERSENSITIVITY (allergic reaction) and PYREXIA (Fever 100.3F) outcome was unknown and SWELLING FACE (woke up with Swollen face/Mouth was not in the right place/Face looked as if she had a stroke/face swallow) and ASTHENIA (Weak) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jul-2022, Body temperature: 103 F. On 29-Jul-2022, Chest X-ray: Normal. On 29-Jul-2022, Computerised tomogram: Normal. On 29-Jul-2022, Electrocardiogram: normal. On 29-Jul-2022, Fibrin D dimer: Normal. On 29-Jul-2022, Full blood count: normal. On 29-Jul-2022, Metabolic function test: Normal. On 29-Jul-2022, Troponin I: Normal. On 29-Jul-2022, Urine analysis: Normal. On an unknown date, Electrocardiogram: normal. On an unknown date, Laboratory test: Normal.         No concomitant medications were reported. The patient had a fever 100.3 F at 10 PM on vaccination day and could not sleep. The next day, on 27-Jul-2022, had chest pain early in the morning and pain all over her body and sweating and visited the emergency room. Electrocardiogram (EKG) and all tests were normal. The patient get Tylenol in the hospital emergency room (ER) and refused to stay overnight. On 28-Jul-2022, the patient woke up with swollen face, her mouth was not in the right place. The face looked as if she had a stroke, and went back to the emergency room. All tests were normal. The ER doctor had not seen anything like that, and did not know what that was. On 05-Aug-2022, the patient was still weak, and the face was still swollen and there was no improvement on the swollen face. Since booster vaccine she had not been able to go to work.   The patient had pregnancy serum test (result provided as normal) on 29-Jul-2022.   Most recent FOLLOW-UP information incorporated above includes: On 07-Aug-2022: Follow-up Received: Patient details, event allergic reaction and shortness of breath and laboratory data updated.